chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I tested positive for COVID-19 on Monday, the 25th. I had the symptoms starting on the 20th. On the 25th, I had a fever of 103.8. Severe body aches, lungs and chest hurt. Headache that won't go away. Severe diarrhea right now - something I have never experienced ever. I have fatigue and nausea. I lost my taste and smell today. I can't taste or smell anything today at all.  I have a cough. My left breast is super, super, super painful. It's very, very painful. It's more by the areola. It's something that I have never experienced ever. It's so, so painful. Last night, I had what felt like what were menstrual like cramps. I have a Merina IUD. I started bleeding this morning, but it's not time for my period. the cramping subsided but I'm taking 800 mg Motrin. The breast pain has not gone away and is very intense. And I'm not having any vaginal bleeding right now, but it was bright, red full blown period this morning. Very odd.  At the Urgent Center, they just told me to take OTC medications for the symptoms. My doctor has offered me the monoclonal infusions but I'm waiting to see how I do. I don't have a fever right now but I'm on Motrin around the clock with Tylenol in-between.  Phone call with Primary Care doctor, too.
Fever; sweats; tingling in hands and feet for 24 hours; This is a spontaneous report from a contactable Consumer(patient). This 65-year-old female patient received first dose of bnt162b2 (BNT162B2, Solution for injection, Lot number: EL1283, Expiry date: unknown), via an unspecified route of administration in Left arm on 25Jan2021 at 12:00 pm as single dose for COVID-19 immunization. Concomitant medication(s) included levothyroxine sodium (Levothyroxin), amlodipine, folic acid, esomeprazole sodium (Nexium). Patient medical history was not reported. On 26Jan2021 at 05:00 am, the patient experienced fever sweats tingling in hands and feet for 24 hours. No treatment was received for the events. The patient was COVID prior vaccination. No COVID test was performed post vaccination. The patient had no allergies. The outcome of the events was reported as recovered on an unknown date in 2021..  Follow-up attempts are completed. No further information is expected.
Patient had almost immediate local reaction. Patient was c/o itchiness and there was moderate amount of erythema surrounding the injection site. Patient was kept in office to monitor. Ice was applied to site. After site was iced for 15 minutes, patient continued to have golf ball sized erythema and some warmth and hardness to injection site. Patient was not worsening, denied headache, difficulty breathing, or tightness of itchiness in throat. She was instructed to continue to ice site on and off throughout the day, take TYLENOL or Ibuprofen, and could use BENADRYL cream for the local reaction. Patient was instructed that if begins to worsen at all to call our office or go to the emergency room. Patient was agreeable to plan.
Felt dizzy not first 15 min but for 20 min after the 15 min initial wt time. Also c/o 10 min of difficulty vocalizing.
Pt presented for covid vax #2  Pt reported puritis at RLQ of abdomen post vaccine administration in the left deltoid  This RN assessed pt: RLQ  of abdomen was pink in color, round, 2 inches, no welts, hives, open areas/wounds noted at site  Pt denied: nausea, sweating, difficulty swallowing, SOB, facial swelling or generalized itching  This RN alerted MD  Pt observed by this RN, offered pt water  MD assessed pt, see MD note  Itching and redness self resolved, per MD: ok for pt to leave vaccine clinic  Pt asking for a BP check- denies HA, visual changes  MD parameters: alert with BP >140/90  BP obtained with small cuff: 142/86, RA, sitting  Repeat BP obtained with large cuff: 132/78, RA, sitting  Pt denied hx of HTN or s/s of HTN Pt denies issues and left ambulatory from vaccine clinic
At 09:20, Hep-B shot was given. At 09:50, returned to nurse's office with mid-sternal chest pain to neck and flushed with chills. Asked to use Albuterol inhaler without relief. EMS arrived, lungs were clear, VSS. At 10:05, she was taken to ER via ambulance. At 10:30, discharged from ER with nebulizer treatment. DX: asthma and anxiety.
pt recv vax in rt arm & upper arm (rt) swollen, inflamed (above elbow to below shoulder) noticed by parent next day, no inc temp etc;
After about 40 minutes post-vaccination in my left arm, I experienced some numbness on left side of my chin/cheek and general nausea. The numbness proceeded up the left side of my face w/no visible drooping, and also included my left arm, left leg and left side of my tongue. Numbness level was like what it feels like as dental novocaine wears off.   Went to ER and had CT scan, bloodwork, and an MRI which ruled out any stroke concerns.  Monday, day after vaccine, I was tired (understandably since in the ER until 4 AM Monday) and had some residual numbness, mostly on my face, some on my arm/leg. Nausea went away after an hour or so on Sunday afternoon and I ate variety of food w/no issues on Sunday and forward. Still have some of the numbness sensations as of Tuesday, mostly feel it in my face. Overall, it feels like half my body got the vaccine and the other half wasn't impacted.
Initially I had Absolutely no symptoms  after I go my booster until last night  Started with  3cm red slightly painful patch at the injection site, we today notably more painful and patch has doubled in size
WOKE UP NEXT MORNING WITH FEVER, CHILLS, BODY ACHES, TOOK IBUPROFEN, VITAMINS B,  C, ZINC, ECHINACEA, ELDERBERRY AND IT RESOLVED BY NEXT MORNING. JUST HAD SORENESS AND MORE PAIN AT INJECTION SITE THAN  I EXPERIENCED AFTER TWO PREVIOUS SHOTS. 12/26/27 - NOTICED ITCH AT INJECTION SITE AND BY AFTERNOON IT WAS RED, RAISED, AND SWOLLEN WITHOUT SCRATCHING OR IRRITATION BY ME. THIS TOOK ABOUT TWO WEEKS TO RESOLVE BUT LEFT A MARK A SHADE DARKER TO MY COMPLEXION AND THE AREA STILL THROBS INTERMITTENTLY TO DATE. 1/22/2021 - HAD FEVER, CHILLS AND BODY ACHE AGAIN THAT RESOLVED BY NEXT MORNING WITH IBUPROFEN, AS LISTED ABOVE.
Extreme body and muscle aches, headaches, fever, cough, swollen red and warm injection site.
9/24/21-9/25/21 102 degree fever, chills, numbing of hands and feet. 9/10 pain in Left injection arm with 0 range of motion.  The next day- bilateral swollen lymphnodes, 100 degree fever. Unable to touch arm or move it. Swollen bilateral lymphnodes and bilateral rash on both armpits.  9/26/21 Day three- swollen lymphnodes and rash along left side of body, down torso, and hip.   9/27/21- Rash under left armpit, swollen lymphnodes
Atrial fibrillation; allergic reaction; flu like symptoms; This spontaneous report was received from a 79 years old male patient referring to himself. The patient had none concomitant medication. Pertinent medical history was reported as atrial fibrillation.   On an unknown date in 2020, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) (Single dose 0.5 ml; route, lot# and expiration date were not reported) given in the arm for preventative measures.     The patient went to his local pharmacy and was given the flu shot and the pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) vaccine. On 04-OCT-2020 (reported as 10 days ago), later that day the patient experienced an allergic reaction were his elbow swelled and it was red (also reported allergic reaction to pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23)). The reaction lasted about 3 days. He also had flu like symptoms which included a fever, aches and pains. The patient explained that he had atrial fibrillation issues as well but he believed that was due to not drinking enough water and staying hydrated and explained that if he did not stay hydrated he had issues with his atrial fibrillation. No treatment was given for AE. The patient had lab diagnostics/studies performed, he had them done annually. Outcome of the events was recovered on an unknown date in October 2020 (reported as 3 days). The patient had not sought medical attention.   The causal relationship between the pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) and the events was not provided.  Upon internal review, atrial fibrillation was determined to be medically significant.
I passed out in the middle of the night and had to crawl back to my bed. I called the doctor on call, who happened to be my doctor, and he said to go to the emergency room, which I did. I was given multiple tests at the emergency room and was given iv fluids. I was released three hours later.
Within 7 hrs of second dose of the Moderna Covid 19 vaccine my arm was very painful at the injection site, I developed a headache and severe fatigue. At 7pm the same evening I developed a fever of 101.2, chills, headache, nausea, severe fatigue and weakness. 24 hrs after the vaccine I was so weak I could not get out of bed, chills, fever, nausea, body-aches, fatigue. I also noticed my whole left arm was swollen. At 48 hrs I had the sweats, chills, fever, body-aches, fatigue, swollen left arm and a 6cm x 6cm circle of hot erythema around the injection site. At 72 hrs most symptoms were gone but I was still fatigued, area around injection site  no longer red but where the erythema was it itched.
Approximately 10 minutes post vax pt experienced feeling diaphoretic and nauseous. Pt appeared flush. Seen in medical clinic. Pt was anxious, diaphoretic and week but recovered after 40 minutes of observation.
Appendicitis; This spontaneous case was reported by a consumer and describes the occurrence of APPENDICITIS (Appendicitis) in a 26-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 051E21A and 053E21A) for COVID-19 vaccination.     No Medical History information was reported.   On 17-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Sep-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 16-Sep-2021, the patient experienced APPENDICITIS (Appendicitis) (seriousness criteria hospitalization, medically significant and life threatening). The patient was treated with Surgery (Patient had appendicitis and had surgery to get it removed) for Appendicitis. At the time of the report, APPENDICITIS (Appendicitis) outcome was unknown.            No concomitant medication details were reported. No treatment medication details was reported. Patient said she was in good health and did not have any underlying medical condition nor takes any medication. However, two days after receiving her second dose patient had appendicitis and had surgery to get it removed.  Company comment - This case concerns a 26-year-old female patient with no relevant medical history, who experienced the unexpected serious event of Appendicitis.  The event occurred approximately 30 days after the second dose of mRNA-1273 (COVID-19 Vaccine Moderna). The rechallenge was not applicable. The benefit-risk relationship of mRNA-1273 (COVID-19 Vaccine Moderna) is not affected by this report.; Sender's Comments: This case concerns a 26-year-old female patient with no relevant medical history, who experienced the unexpected serious event of Appendicitis.  The event occurred approximately 30 days after the second dose of mRNA-1273 (COVID-19 Vaccine Moderna). The rechallenge was not applicable. The benefit-risk relationship of mRNA-1273 (COVID-19 Vaccine Moderna) is not affected by this report.
My arm became very sore and painful to move about 2 hours after receiving injection. Range of motion was limited to about 15 degrees. This lasted 3 days. I still have pain when moving my left arm in a full range of motion
PT hospitalized within 6 weeks of receiving COVID vaccine on 2-23-21 for 6 days and on 3-18 for 8 days
Fever of 101.4; Chills; Aches; Fatigue; This is a spontaneous report from a contactable consumer.  A 76-years-old female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in Arm Left on 29Jan2021 (Batch/Lot Number: EL9263) as SINGLE DOSE for an unspecified indication.  Medical history included ongoing acute myeloid leukaemia, ongoing hypertension. Concomitant medications included gilteritinib fumarate (XOSPATA) taken for an unspecified indication, start and stop date were not reported; timolol taken for an unspecified indication, start and stop date were not reported; lisinopril taken for an unspecified indication, start and stop date were not reported; levothyroxine (LEVOTHYROXINE) taken for an unspecified indication, start and stop date were not reported; latanoprost (LATANOPROST) taken for an unspecified indication, start and stop date were not reported; hydrochlorothiazide (HYDROCHLOROTHIAZIDE) taken for an unspecified indication, start and stop date were not reported.  The patient experienced fever of 101.4 (pyrexia) (non-serious) on 30Jan2021 10:00, chills (chills) (non-serious) on 30Jan2021 10:00, aches (pain) (non-serious) on 30Jan2021 10:00, fatigue on 30Jan2021 10:00.  The patient underwent lab tests and procedures which included body temperature: 101.4 on 30Jan2021.  There was not treatment received for the adverse events. The events were considered as non-serious by the other healthcare professional. The outcome of the events were reported as recovered.
Awakened with throbbing pain in the entire left arm (shoulder to fingertips). Numbness/tingling in left ring and pinky finger. Tenderness/swelling in the left armpit.  Aching arm followed for a few days, but axillary swelling persisted for about 10 days. Occasional tingling in fingers is still present 2 weeks later.
pt recvd vax 27OCT94 & 28OCT94 exp ache behind rt ear & base of neck gradually worked around to front over lt eye-sometimes a sharp pain; 30OCT94 around 5PM h/a w/real sharp pain; 530PM rt sided of face had dropped & rt eye would not close;
Patient went to pharmacy to receive his 2nd dose of Moderna COVID 19 vaccine 12 days later; This spontaneous case was reported by a nurse and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient went to pharmacy to receive his 2nd dose of Moderna COVID 19 vaccine 12 days later) in a 19-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026C21A) for COVID-19 vaccination. No Medical History information was reported. On 23-Jul-2021 at 1:15 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Aug-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Aug-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient went to pharmacy to receive his 2nd dose of Moderna COVID 19 vaccine 12 days later). On 04-Aug-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient went to pharmacy to receive his 2nd dose of Moderna COVID 19 vaccine 12 days later) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medication information was provided. No treatment medication information was provided. Most recent FOLLOW-UP information incorporated above includes: On 27-Aug-2021: Follow up received contains non significant information. Phone number updated from original source document. Patient demographics updated. Vaccine facility information updated.
Received Flu Mist 10/24/14. On Thursday 10/28/14, developed sore throat, cough and stomach update persisted and een on 11/3/14.
GUILLAIN-BARRE SYNDROME/UNABLE TO WALK; COULD NOT FUNCTION PROPERLY; This spontaneous report received from a consumer via Social media concerned a 28 year old female of unspecified race and ethnicity. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2. (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported, 1 total administered for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On an unspecified date, it was reported that "my 28 year old daughter received j&j shot, she woke up in the morning and was unable to walk. The patient visited emergency room during a pandemic and she waited 14 hours before she could be seen. After 2 days of invasive tests (unspecified) they narrowed it down to either multiple sclerosis or Guillain-Barre syndrome. On an unspecified date, more tests (unspecified) were performed and there was no finding of any lesions on her brain. The patient was diagnosed with Guillain-Barre syndrome and was hospitalized (dates unspecified). The patient received hemoglobin treatment for 2 months in hospitals and a rehabilitation hospitals. The patient was finally able to come home and continued physical therapy for another couple of months. Still patient could not function properly". The duration of hospitalization was not reported. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from could not function properly, and the outcome of guillain-barre syndrome was not reported. This report was serious (Hospitalization Caused / Prolonged).; Sender's Comments: V0. 20220311045-covid-19 vaccine ad26.cov2.s -Guillain barre syndrome . This event(s) is labeled per RA and is therefore considered potentially related.
She feels her heart is racing; This is a spontaneous report from a contactable consumer (Parent). A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot Number and Expiry date was not reported), via an unspecified route of administration on 11Sep2021 as dose 2, single for COVID-19 immunization. The patient medical history and concomitant medications was not reported. Previously patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: solution for injection, Batch/Lot Number and Expiry date was not reported), via an unspecified route of administration on unspecified date as dose 1, single for COVID-19 immunization. On Sep2021, the patient experienced she feels her heart is racing.   Reporter stated that her daughter received her 2nd shot yesterday for Covid 19 Vaccine and she saying that she feels her heart is racing today now, she guess her question is on the myocarditis stop when it does take the place, does the heart actually race or is just the way you feel it racing. When paraphrased the concern, Reporter stated, Correct and informed about role of Pfizer Drug Safety and Pfizer Medical Information and provided with the number as # and requested to dial and informed about timings as 8 AM to 8 PM from Monday to Friday as per EST. Reporter added, Where can she get the information as of today on Sunday instead of Monday because her daughter feels her heart is racing and she need medical information on that. Reporter was informed to contact physician and informed about call back requested when the Pfizer medical information department is open. However, Reporter deny for call back and stated, "No thats wont be necessary, she just call the doctor (Hence call back request was not made), thats should be all she need as far as thing she get. When requested for further probing, Reporter stated, she don't have time, she need to call a doctor, she need to call doctor because her daughter is serious, so she don't have time for question now. No further information could be probed as the reporter hung up the call abruptly. Hence, limited information available over the call. The patient underwent lab tests and procedures which included heart rate variability test: unknown on heart is racing. The outcome for the event she feels her heart is racing was unknown.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Case number PHEH2016US029916, is an initial spontaneous report from a pharmacist received on 11 Nov 2016. This report refers to an unknown age of female patient. Past medical history and concomitant medication were not reported. The patient was vaccinated with single dose of FLUVIRIN (batch number: not reported) at a dose of 0.25 ml, intramuscularly on 07 Nov 2016. Pharmacist reported that, a patient stopped by and told him that a 1/2 dose of FLUVIRIN was administered at another pharmacy 04 days ago on Mon 07 Nov 2016 to see if the person would have an allergic reaction. Now, the patient wants him to administered the other half on 11 Nov 2016. No adverse event reported following this medication error (underdose). The case was assessed as non serious by the pharmacist.
PER MOTHER, "SMALL PATCHES" ECZEMA RASH 4 DAYS POST VACCINATION ON 1/2/2021  1/26/21 ALLERGY CONSULT DIAGNOSED WITH SEVERE ATOPIC DERMATITIS; POSITIVE ALLERGY TO MILK AND CASEIN; RECOMMENDS SWITCHING FORMULAS FROM NUTRAMIGEN TO PROSOBEE AND AVOIDING MILK AND CASEIN-BASED PRODUCTS 2/1/21 9:30 AM PHONE NOTE FROM MOTHER TO ALLERGIST STATES "PT'S FACE & MOST OF SKIN HAS CLEARED UP AND HE IS DOING GREAT"  PLATELETS ELEVATED AT 608 K/CMM EOS ELEVATED AT 9% LYMPHS (ABSOLUTE) ELEVATED AT 10.9 K/CMM MONOCYTES (ABSOLUTE) ELEVATED AT 1.5 K/CMM EOS (ABSOLUTE) ELEVATED 1.7 K/CMM BASO (ABSOLUTE) ELEVATED 0.2  IGE MILK 0.43 KU/L CLASS I IGE WHEY 0.24 KU/L CLASS 0/I IGE CASEIN 0.21 KU/L CLASS 0/I
Aug 10th 2008 - Pt c/o paresthesias, numbness on bottom of feet. Aug 20 - sensory exam WNL by neurologist. Muscle weakness more in arm than legs. R/O [[name]] Barre'. Aug 20 - Aug 28 - Hospitalized and admin IVIG 400 mg/kg.  12/31/08 Reviewed hospital medical records of 8/20-8/27/08. FINAL DX: acute polyradiculopathy c/w [[name]] Barre syndrome; HTN. Records reveal patient exprienced bilateral progressive leg numbness & pain, generalized weakness x 10 days.  Had received vaccines on 9/23 in preparation for out of country travel.  Neuro consult done.  Hyporeflexic throughout & areflexia of knees & ankles.  Tx w/IVIG x 5 days.  Improved & d/c to home w/outpatient PT & neuro f/u.  10/17/08 Reviewed hospital medical records of 9/1-9/18/2008. FINAL DX: demyelinating polyneuropathy, GBS, right Bell's palsy Records reveal patient experienced right facial weakness, blurry vision & UE weakness.  Had been d/c from hospital on 8/27 bilateral leg numbness & diffuse weakness in UE & [[name]]s; tx w/IVIG x 5 days at that admission.  Exam revealed absent ankle reflexes & decreased reflexes elsewhere.  Slow improvement & admitted to inpatient rehab.  12/5/08 Reviewed hospital medical records of 9/18-9/29/2008 and 9/29-10/9/2008. FINAL DX: [[name]] Barre syndrome. Records reveal patient experienced paresthesias of bilateral [[name]]s.  Admitted 8/2008 for suspected GBS.  Returned 9/1 as noted above.  While in rehab, developed new left facial weakness, bilateral UEs weakness, numbness & tingling.  Admitted to acute care 9/18 w/malaise, weakness, intermittent blurry vision, bilatera [[name]] pain.  Tx w/plasma phareses & steroids.  Motor strength improved dramatically.  Transferred to inpatient rehab for continued biweekly plasma exchanges.  Upon d/c from rehab, continued on crutches w/pain meds, w/assist to continue w/neuro f/u as outpatient for continued plasmapharesis & outpatient PT/OT.